Budget Amount *help |
¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2022: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2021: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2020: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2019: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2018: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
|
Outline of Final Research Achievements |
In adhesion assay using B cell lymphoma cell line, cell adhesion to galectins was enhanced by anti-IgM antibody in HBL-2 cells suggesting glycosylation of IgM may be associated with cell adhesion to galectins. In adhesion assay using Burkitt lymphoma cell line, cell adhesion to galectins was enhanced by alteration of cell surface sialylation with sialic acid analogue. These results suggested that cell surface sialic acids may be a target for therapy of human malignant lymphoma.
|